Molecular basis of human ATM kinase inhibition

Nat Struct Mol Biol. 2021 Oct;28(10):789-798. doi: 10.1038/s41594-021-00654-x. Epub 2021 Sep 23.

Abstract

Human checkpoint kinase ataxia telangiectasia-mutated (ATM) plays a key role in initiation of the DNA damage response following DNA double-strand breaks. ATM inhibition is a promising approach in cancer therapy, but, so far, detailed insights into the binding modes of known ATM inhibitors have been hampered due to the lack of high-resolution ATM structures. Using cryo-EM, we have determined the structure of human ATM to an overall resolution sufficient to build a near-complete atomic model and identify two hitherto unknown zinc-binding motifs. We determined the structure of the kinase domain bound to ATPγS and to the ATM inhibitors KU-55933 and M4076 at 2.8 Å, 2.8 Å and 3.0 Å resolution, respectively. The mode of action and selectivity of the ATM inhibitors can be explained by structural comparison and provide a framework for structure-based drug design.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adenosine Triphosphate / analogs & derivatives
  • Adenosine Triphosphate / metabolism
  • Ataxia Telangiectasia Mutated Proteins / antagonists & inhibitors*
  • Ataxia Telangiectasia Mutated Proteins / chemistry*
  • Ataxia Telangiectasia Mutated Proteins / genetics
  • Ataxia Telangiectasia Mutated Proteins / metabolism
  • Binding Sites
  • Catalytic Domain
  • Cryoelectron Microscopy
  • Humans
  • Models, Molecular
  • Morpholines / chemistry
  • Morpholines / metabolism
  • Mutation
  • Neoplasms / genetics
  • Protein Conformation
  • Protein Kinase Inhibitors / chemistry*
  • Protein Kinase Inhibitors / metabolism*
  • Pyrones / chemistry
  • Pyrones / metabolism

Substances

  • 2-morpholin-4-yl-6-thianthren-1-yl-pyran-4-one
  • Morpholines
  • Protein Kinase Inhibitors
  • Pyrones
  • adenosine 5'-O-(3-thiotriphosphate)
  • Adenosine Triphosphate
  • ATM protein, human
  • Ataxia Telangiectasia Mutated Proteins